vs

Side-by-side financial comparison of Hilltop Holdings Inc. (HTH) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $300.5M, roughly 1.6× Hilltop Holdings Inc.). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs 6.8%, a 6.2% gap on every dollar of revenue. Over the past eight quarters, Hilltop Holdings Inc.'s revenue compounded faster (0.6% CAGR vs -0.1%).

Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

HTH vs MD — Head-to-Head

Bigger by revenue
MD
MD
1.6× larger
MD
$493.8M
$300.5M
HTH
Higher net margin
HTH
HTH
6.2% more per $
HTH
13.0%
6.8%
MD
Faster 2-yr revenue CAGR
HTH
HTH
Annualised
HTH
0.6%
-0.1%
MD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
HTH
HTH
MD
MD
Revenue
$300.5M
$493.8M
Net Profit
$39.0M
$33.7M
Gross Margin
Operating Margin
9.9%
Net Margin
13.0%
6.8%
Revenue YoY
-1.7%
Net Profit YoY
-12.4%
10.5%
EPS (diluted)
$0.64
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTH
HTH
MD
MD
Q1 26
$300.5M
Q4 25
$329.9M
$493.8M
Q3 25
$330.2M
$492.9M
Q2 25
$303.3M
$468.8M
Q1 25
$318.5M
$458.4M
Q4 24
$301.1M
$502.4M
Q3 24
$305.5M
$511.2M
Q2 24
$297.0M
$504.3M
Net Profit
HTH
HTH
MD
MD
Q1 26
$39.0M
Q4 25
$41.6M
$33.7M
Q3 25
$45.8M
$71.7M
Q2 25
$36.1M
$39.3M
Q1 25
$42.1M
$20.7M
Q4 24
$35.5M
$30.5M
Q3 24
$29.7M
$19.4M
Q2 24
$20.3M
$-153.0M
Operating Margin
HTH
HTH
MD
MD
Q1 26
Q4 25
16.1%
9.9%
Q3 25
18.4%
13.8%
Q2 25
16.3%
12.8%
Q1 25
18.1%
7.0%
Q4 24
14.7%
7.8%
Q3 24
13.9%
6.6%
Q2 24
10.0%
-31.3%
Net Margin
HTH
HTH
MD
MD
Q1 26
13.0%
Q4 25
12.6%
6.8%
Q3 25
13.9%
14.5%
Q2 25
11.9%
8.4%
Q1 25
13.2%
4.5%
Q4 24
11.8%
6.1%
Q3 24
9.7%
3.8%
Q2 24
6.8%
-30.3%
EPS (diluted)
HTH
HTH
MD
MD
Q1 26
$0.64
Q4 25
$0.68
$0.40
Q3 25
$0.74
$0.84
Q2 25
$0.57
$0.46
Q1 25
$0.65
$0.24
Q4 24
$0.55
$0.37
Q3 24
$0.46
$0.23
Q2 24
$0.31
$-1.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTH
HTH
MD
MD
Cash + ST InvestmentsLiquidity on hand
$375.2M
Total DebtLower is stronger
$990.8M
$570.5M
Stockholders' EquityBook value
$2.2B
$865.9M
Total Assets
$15.7B
$2.2B
Debt / EquityLower = less leverage
0.46×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTH
HTH
MD
MD
Q1 26
Q4 25
$375.2M
Q3 25
$340.1M
Q2 25
$224.7M
Q1 25
$99.0M
Q4 24
$229.9M
Q3 24
$103.8M
Q2 24
$19.4M
Total Debt
HTH
HTH
MD
MD
Q1 26
$990.8M
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Stockholders' Equity
HTH
HTH
MD
MD
Q1 26
$2.2B
Q4 25
$2.2B
$865.9M
Q3 25
$2.2B
$890.7M
Q2 25
$2.2B
$833.8M
Q1 25
$2.2B
$789.2M
Q4 24
$2.2B
$764.9M
Q3 24
$2.2B
$732.5M
Q2 24
$2.1B
$706.5M
Total Assets
HTH
HTH
MD
MD
Q1 26
$15.7B
Q4 25
$15.8B
$2.2B
Q3 25
$15.6B
$2.2B
Q2 25
$15.4B
$2.1B
Q1 25
$15.8B
$2.0B
Q4 24
$16.3B
$2.2B
Q3 24
$15.9B
$2.1B
Q2 24
$15.6B
$2.0B
Debt / Equity
HTH
HTH
MD
MD
Q1 26
0.46×
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTH
HTH
MD
MD
Operating Cash FlowLast quarter
$114.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTH
HTH
MD
MD
Q1 26
Q4 25
$-38.7M
$114.1M
Q3 25
$273.0M
$137.3M
Q2 25
$-234.6M
$137.2M
Q1 25
$5.8M
$-117.5M
Q4 24
$273.9M
$133.0M
Q3 24
$515.6M
$91.8M
Q2 24
$-435.3M
$107.0M
Free Cash Flow
HTH
HTH
MD
MD
Q1 26
Q4 25
$-55.5M
Q3 25
$271.0M
Q2 25
$-234.6M
Q1 25
$5.0M
Q4 24
$266.8M
Q3 24
$513.8M
Q2 24
$-437.3M
FCF Margin
HTH
HTH
MD
MD
Q1 26
Q4 25
-16.8%
Q3 25
82.1%
Q2 25
-77.4%
Q1 25
1.6%
Q4 24
88.6%
Q3 24
168.2%
Q2 24
-147.2%
Capex Intensity
HTH
HTH
MD
MD
Q1 26
Q4 25
5.1%
Q3 25
0.6%
Q2 25
0.0%
Q1 25
0.3%
Q4 24
2.4%
Q3 24
0.6%
Q2 24
0.7%
Cash Conversion
HTH
HTH
MD
MD
Q1 26
Q4 25
-0.93×
3.39×
Q3 25
5.96×
1.91×
Q2 25
-6.50×
3.49×
Q1 25
0.14×
-5.66×
Q4 24
7.71×
4.36×
Q3 24
17.36×
4.72×
Q2 24
-21.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HTH
HTH

Noninterest Income$188.4M63%
Net Interest Income$112.1M37%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons